The NIH Revitalization Act of 1993 was signed
On Jun. 10, 1993, the U.S. Congress signed the National Institutes of Health Revitalization Act, P.L. 103-43. The…
-
-
ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam Plant building
On May 13, 1993, ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam…
-
The first gene associated with hereditary nonpolyposis colon cancer was cloned (hMSH2)
On May 7, 1993, the first gene associated with hereditary nonpolyposis colon cancer (HNPCC) was cloned (hMSH2). People…
-
The CDC responded to a Hantavirus outbreak in the southwestern U.S.
On May 14, 1993, the New Mexico Department of Health (NMDOH) reported it was notified by the Office…
-
The costs of influenza vaccine and its administration became a covered benefit under Medicare Part B
On May 1, 1993, the costs of influenza vaccine and its administration became a covered benefit under Medicare…
-
CDC reponded to E. coli Outbreak from Hamburgers in Western United States
On Apr. 16, 1993, the U.S. Centers for Disease Control (CDC) reported that from November 15, 1992, through…
-
Biotechnology | Chemistry | Disease | FDA | Therapeutics
The Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established
On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…
-
James Watson resigned as head of Human Genome Project over NIH efforts to patent gene fragments
In April 1993, James Watson resigned as head of National Human Genome Research Institute (NCHGR) following allegations that…
-
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the U.S. Food and Drug Administration (FDA) approved Amgen’s Epogen/Procrit for the treatment of…
-
A combined Haemophilus influenzae type b vaccine and whole cell DTP vaccine was licensed
On Mar. 30, 1993, the Food and Drug Administration (FDA) approved a combined diphtheria and tetanus toxoids and…
-
The FDA approved use of a new haemophilus b conjugate vaccine for infants and children
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
-
The Pappajohn Clinical Cancer Center opens for service
In 1993, the John and Mary Pappajohn Clinical Cancer Center opened for service after receiving a generous $25…
-
Biotechnology | CDC | HIV
The CDC revised its definition of AIDS to include all HIV-infected people who have CD4 T cells count <200 ul or a CD4 T cells percentage <14
In 1993, The U.S. Centers for Disease Control and Prevention (CDC) revised its definition of AIDS to include…
-
Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
-
Agriculture | Biotechnology | FDA | U.S. Congress | USDA
FDA declared genetically-engineered foods are not inherently dangerous and do not require special regulation
In 1993, the U.S. Food and Drug Administration (FDA) declared genetically-engineered foods are not inherently dangerous and do…
-
Drs. Joan and Ron Conaway at the OMRF discovered Elongin a genetic transcription factor
In 1993, Drs. Joan and Ron Conaway from the Oklahoma Medical Research Foundation (OMRF) discovered Elongin A (EloA)…
-
FDA added new CBER reviewers to streamline biologics review and user fees were enacted
In 1993, The U.S. Food and Drug Administration (FDA) added new CBER reviewers to streamline biologics review. User…
-
The Physicians Pavilion opened at OHSU on Marquam Hill to provide modern outpatient services
In 1993, the Physicians Pavilion at Oregon Health & Science University (OHSU) opened on Marquam Hill to provide…
-
The Institute of Medicine published “The Children’s Vaccine Initiative”
In 1993, The Institute of Medicine published “The Children’s Vaccine Initiative: Achieving the Vision.” The Children’s Vaccine Initiative…
-
Oregon Health Policy Institute, an interdisciplinary center of OHSU, Portland State University and Oregon State University was created
In 1993, Oregon Health Policy Institute, an interdisciplinary center of Oregon Health & Science University (OHSU), Portland State…
-
The development of immunization registries was promoted at the national level
In 1993, the development of immunization registries was promoted at the national level. A national health goal for…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
The Hollings Cancer Center was founded
In 1993, The Hollings Cancer Center (HCC) was formally was established and named for former U.S. Senator and…
-
Michael Smith was awarded Nobel Prize in Chemistry
In 1993, Dr. Michael Smith from the University of British Columbia in Vancouver was awarded one half the…
-
Vanderbilt Cancer Center was established
In 1993, the Vanderbilt Cancer Center was established under the leadership of Dr. Hal Moses, to bring together…
-
Stanford Medicine researchers demonstrated that lifestyle changes and drug therapy decrease heart attack rates
In 1993, Stanford Medicine researchers led by William Haskell demonstrated that lifestyle changes and drug therapy decrease heart…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The Cancer Therapy & Research Center at San Antonio received NCI designation
In 1993, The Cancer Therapy & Research Center (CTRC) at San Antonio received National Cancer Institute (NCI) designation….
-
Kary B. Mullis was awarded Nobel Prize in Chemistry
In 1993, Kary B. Mullis of La Jolla, CA and a graduate of the University of California at…
-
Jon M and Karen Huntsman donated $10 million to the University of Utah to establish a cancer institute
In 1993, Jon M. and Karen Huntsman donated $10 million to the University of Utah to establish a…
-
UCSF discovered genes that double lifespan of C. elegans, linked to longevity in other species
In 1993, University of California, San Francisco (UCSF) researchers Cynthia Kenyon and colleagues’ announced they had discovered that…
-
Immunex merged with American Cyanamid’s Lederle Oncology business
On Dec. 21, 1992, Immunex announced a merger agreement with American Cyanamid Company’s Lederle Oncology business. In Nov….
